...
机译:抑制血浆Kallikrein用于遗传性血统的预防
Massachusetts Gen Hosp Harvard Med Sch Dept Med Div Rheumatol Allergy &
Immunol Boston MA;
Icahn Sch Med Mt Sinai Dept Med Div Clin Immunol &
Allergy New York NY 10029 USA;
Triumpharma Amman Jordan;
Asthma &
Allergy Res Associates Dallas TX USA;
Winthrop Univ Hosp Mineola NY Jordan;
Washington Univ Sch Med Div Allergy &
Immunol St Louis MO USA;
Allergy &
Asthma Med Grp Walnut Creek CA USA;
Baker Allergy Asthma &
Dermatol Lake Oswego OR USA;
Univ Cincinnati Coll Med Dept Internal Med Allergy Sect Cincinnati Cincinnati OH USA;
Univ S Florida Morsani Coll Med Dept Internal Med Div Allergy &
Immunol Tampa FL USA;
Inst Asthma &
Allergy Chevy Chase MD USA;
Penn State Hershey Allergy Asthma &
Immunol Dept Med &
Pediat Hershey PA USA;
Univ Milan Dept Biomed &
Clin Sci Luigi Sacco I-20122 Milan Italy;
Univ Calif San Diego Dept Rheumatol Allergy &
Immunol San Diego CA 92103 USA;
Triumpharma Amman Jordan;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
ICON Clin Res Marlborough MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
Dyax Burlington MA USA;
机译:口腔血浆Kallikrein抑制剂在遗传血管后血统的预防
机译:口服Kallikrein抑制剂的Avoralstat评估,在第3期遗传性血管型预防试验中:Opus Opus -2?研究
机译:遗传性血管性水肿患者对C1酯酶抑制剂的过敏反应:人血浆激肽释放酶抑制剂DX-88的成功治疗
机译:蠕虫治疗遗传性血统血统:一种基于新型治疗选择的理论模型
机译:筛选天然产物对激肽释放酶激肽系统的影响:遗传性血管性水肿治疗的潜在影响。
机译:口服激肽释放酶抑制剂avoralstat在3期遗传性血管性水肿预防试验中的评估:OPuS-2研究
机译:口服血浆Kallikrein抑制剂BCX7353是安全有效的,作为遗传血统(HAE)患者的血管模型攻击的按需治疗:Zenith-1试验的结果
机译:阐明遗传性血管性水肿中突变型C1抑制蛋白增强毒性功能的机制。